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Background: Tools which assist practitioners to identify patient concerns and increase under-
standing of their needs can improve both the delivery of care and adherence to treatment. The
aim of this study was to test the validity and reliability of a 14-item tool, to identify the unmet
needs and concerns of older people with asthma.
Methods: The Patient Asthma Concerns Tool (PACT) was developed from a pool of 55 items
derived from a comprehensive literature review. After pilot and field testing, the initial 55
item questionnaire was administered to a community sample (n Z 193), psychometrically
tested, and refined to a 14 item PACT tool which was evaluated by a group of clinicians.
Results: The PACT was shown to have good content and construct validity and was well
received by clinicians. The PACT also correlated well with the Juniper ACQ and Brooks’ adher-
ence score on related variables and showed good reliability with goodeexcellent Kappa and
ICC scores. Internal consistency of factors was high, and the overall Cronbach’s a was 0.70.agement Group, Co-operative Research Centre for Asthma and Airways, Woolcock Institute of Medical
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Lung function (mean FEV1% predic
ACQ (mean  SD)
Adherence score (mean  SD)
a Data unavailable from pilot samp
b Results refer to a sub-sample (n
delineation in adherence out of a p
medication.Conclusion: The PACT questionnaire was shown to be a valid and reliable tool clinically and
psychometrically. We intend to test it in primary care settings and anticipate that its use will
assist health professionals to identify the needs and concerns of older patients with asthma
and direct tailored asthma management accordingly.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Improving asthma outcomes in older people is a major
challenge. The ability of primary care physicians to discuss
underlying patient concerns is associated with better
patient adherence to recommendations, patient and
physician satisfaction and increased patient involvement in
their treatment.1,2 In medical consultations however, the
older patients’ concerns often remain unvoiced and
unrecognised. In the management of diabetes, concerns
about medication costs, side effects and a desire to reduce
medication burden, have been shown to lead to non-
adherence.3 Similar issues have been observed in the
management of asthma.4 Asthma in older people is poorly
understood in the community and many older people live
with unmet concerns about their asthma and asthma
treatment.5e8 The evidence also suggests that older people
play down their symptoms, while an increasing proportion
of older people are dying from asthma.7
Under-recognition and reporting of symptoms affects
management in primary care settings. This is a concern
particularly given the ageing population in most Wester-
nised countries and the increasing numbers of potentially
affected people. The older patient’ and the physicians view
of unmet needs can differ considerably,9 and communica-
tion is impeded when clinicians are not specific and
patients do not volunteer information regarding their
concerns or asthma related problems.8 A lack of validation
of patients’ concerns remains a major cause of discontent
with their medical practitioner.10 As such, practitioners
may be assisted by a simple tool such as a questionnaire to
address patients’ perceived needs. It is likely that better
communication between physicians and older patients











Z 44) of the community study
ossible total of 6. Adherence (n Zoutcomes in older people,11 although randomised trials
demonstrating this and justifying the inclusion of such
principles in asthma guidelines are awaited.10e12
The use of pre-visit questionnaires has been recognised
as an effective method for enhancing patients’ involvement
in their care and for identifying potentially unrecognised
concerns.1,14 We therefore designed the Patient Asthma
Concerns Tool (PACT) to allow older patients to communi-
cate their asthma concerns and needs and to help physi-
cians identify issues which should be addressed. The
purpose of this paper is to present the psychometric
development and validation of the PACT instrument.
Methods
In the first stage we developed a survey, the Asthma Needs
Questionnaire (ANQ), to determine the unmet needs and
concerns of older people with asthma, with a specific focus
on asthma management behaviour, education, care and
treatment. In the second stage we conducted psychometric
testing and refinement to produce the 14 item PACT
questionnaire.
Study population
Participants were recruited from two sites, in NSW and
Victoria [Table 1]. Eligible participants were aged over 55
years and had a doctor diagnosis of asthma. They were ex-
or non-smokers had smoked <10 pack years.
The pilot sample (n Z 32) was randomly selected from
a volunteers’ database (Woolcock) and outpatient waiting
areas (Alfred Hospital). The field-testing stage recruited
a new sample (n Z 41) of participants using the sameField study Community study
40 193
70  9 68  9
19 (46) 70 (36)
22 (54) 123 (64)
100% 83%
78%  21 80%  29b
1.1  0.7 1.4  1.1b
1.7  1.4 1.9  1.5b
where lung function was measured. Adherence score refers to
32) 12/44 participants were not currently taking any preventer
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population sample (n Z 193) were then recruited to
confirm the findings. These participants were recruited
from 53 regional and metropolitan pharmacies in Victoria
and NSW. Participants were invited by their pharmacist to
participate in the study. A final sample (nZ 26) tested the
refined questionnaire.
Stage 1: questionnaire development
A comprehensive literature review5 and a mixed methods
study, which included in-depth interviews to explore the
attitudes and experiences of older people with asthma6 was
used to develop a self-administered 55 item survey (145
possible scale responses), the ANQ.
Items were grouped under the domains of: diagnosis,
symptoms, management behaviour, medication adherence
and barriers, practitioner care, patient knowledge, beliefs,
and exacerbation concerns. The ANQ included a combina-
tion of ‘yes/no’ questions, agree/disagree, multiple
choice, 4-point and 5-point scale questions. Open ended
questions were also included where more detailed infor-
mation was needed. The Control Preferences Scale, which
is a valid reliable measure of health-care decision-making
preferences, was also incorporated as a single question to
analyse participants’ decision-making preferences in
regards to their asthma management.12 Information
regarding demographic, current treatment and medical
history was also collected to explore any differences in
needs and concerns according to these factors.Pilot testing
A convenience sample (nZ 32) pilot tested the ANQ survey.
Acceptability of the questionnaire was assessed in terms of
interpretability and completion rates. Changes were made
to the wording, instructions provided and the structure of
the questionnaire where misunderstanding or uncertainty
was observed. A few questions were separated to address
issues more specifically and a few further questions were
included to improve appropriateness.
After the pilot testing, the ANQ was field tested and used
in a larger community based cohort (n Z 193) to evaluate
the generalisability of question responses. A descriptive
analysis of the results of responses to the ANQ as a whole
has been published elsewhere.13
The Human Research Ethics Committees (HREC) of both
institutions approved all phases of the study.
Stage 2: item reduction and development of the Patient
Asthma Concerns Tool
The purpose of this stage was to produce a concise tool for
use by clinicians and researchers which would identify older
patients’ unmet needs and concerns in order to develop
personalised clinical management strategies.
Demographic items in the initial survey were removed
and the construct validity of the ANQ items tested. Reli-
ability and internal consistency of the remaining questions
were then assessed in the new form and pilot tested in
a group of participants.
A group of general practitioners were also invited to
review the questionnaire as a tool for clinical use accordingto the relative importance of each individual item and the
overall ease of use and relevance in identifying patient
concerns and guiding asthma management.
Data analysis
Validity
The content validity of the initial survey was measured by
the extent to which it adequately covered the areas iden-
tified in the literature and qualitative studies. Two respi-
ratory physicians and a medical sociologist were involved in
further refining the questionnaire items for inclusion.
There is currently no gold standard with which to
compare the criterion validity of asthma needs or asthma
concerns questionnaire. Hypothesis testing can however be
used to measure components of the questionnaire against
validated questionnaires which focus on these particular
constructs. We did this using the Juniper Asthma Control
Questionnaire (ACQ)14 and the Brooks adherence score.15
Both have been validated and used in other studies and
were considered to be suitable for comparison with this
asthma tool.
Relevant variables were measured against the ACQ and
Adherence score using Spearman’s rank correlation coeffi-
cient. We hypothesised that for the questionnaire to be
a valid assessment, a higher ACQ score would be observed
in participants indicating poorer asthma control in our
questionnaire, i.e. reporting more asthma symptoms,
restrictions, and health care utilisation. Similarly we pre-
dicted a higher adherence score, indicating poorer adher-
ence, would be associated with lower self reported
medication adherence, greater financial concern and
a higher reporting of side effects and worry about side
effects.
Factor analysis is commonly used in data reduction to
test hypothesis structures.16 It provides a statistical
measure to investigate the underlying constructs of the tool
and observe inter-relationships between variables.17,18 The
items generated for the ANQ survey were first analysed in
order to determine homogeneity and establish whether the
items could be measured together or needed to be
considered separately. This was used to confirm the theo-
retical structure of the domains we hypothesised. It was
predicted that items would correlate well within each
domain and would produce only weak associations when
compared against variables in other domains. Factor anal-
ysis was then applied to reduce the ANQ items into a more
concise tool for clinical use. Exploratory principles
component analysis using a promax oblique rotation and
a Kaiser criterion with an eigenvalue >1.0 was applied to
investigate correlations. Items with poor factor loading
were considered for removal and confirmed by the
researchers’ consensus.
Testeretest reliability
The stability of both the initial survey and final PACT tool
were determined by measuring reproducibility. Participants
(n Z 40) were asked to complete the questionnaires twice
over a 2e4 week interval and responses compared. The
1504 M.A. Crane et al.repeatability of the categorical, nominal questions was
measured by calculating Kappa (l), an estimate of the
agreement between administrations of the questionnaire.19
The Intraclass Correlation Coefficient (ICC) was calculated
for the remaining ordinal questions.
Internal consistency
Cronbach’s a coefficient was used to measure the degree of
association between variables within the theoretical
domains which had earlier been confirmed using factor
analysis. The item-to-total value was then measured to
investigate a coefficient if each item was removed.
Statistical analysis
Statistical analysis was carried out using SPSS version 16
(Statistical Package for Social Scientists Inc, Chicago, USA).
Results
The descriptive details of the study stages are provided in
Table 1.
Validity of the initial community survey
Content validity
Following pilot testing, the face and content validity of the
ANQ survey was good, evidenced by the low rate of missing
responses observed in the study samples, and suggesting its
ability to gather concrete information. In the field study,
response rate was high, with only 2 of the 55 questions
missing up to 10% of responses. One of these questions
asked after income levels. The other referred to general
medication side effects and was presented at the bottom of
a page that was not applicable for many participants.
Construct validity
Internal consistency of the 55 item ANQ survey was calcu-
lated within its theoretical domains. Cronbach’s a coeffi-
cients for the domains were as follows: symptoms (16 item)
0.77, self-management (13 item) 0.17, medication adher-
ence barriers (8 item) 0.14, beliefs (12 item) 0.55, access
barriers (3 item) 0.27, exacerbation concerns (3 items) 0.75
and knowledge (3 items) 0.84. The relationship between
items when one item was removed was improved only in the
self-management domain to a Z 0.42 when the variable
‘my asthma is never out of control’ was removed. Cron-
bach’s a coefficients were not increased by the removal of
items in any of the other domains.
Criterion-related validity
Concern items correlated well with other validated
measures. Questions regarding preventer adherence were
significantly associated with the Brooks adherence score
when asked “how often do you take your medication
exactly as the doctor prescribed” [Table 2].
The symptom and control related items correlated well
with the ACQ score. The results from the field sample were
then compared with the community sample to confirmfindings. The severity of asthma symptoms and restriction
during usual activities experienced in the community
sample was more highly correlated with ACQ score. This
was consistent with a higher rating of symptom severity,
restriction and health care use and higher overall ACQ score
in this sample.
Concern items were also able to discriminate between
patients’ reported asthma control as assessed by a vali-
dated score, the ACQ.23 It was predicted that patient
reporting of a high degree of symptoms would correspond
with a higher ACQ score (>1.2) and that patient reporting
experience of slight or no symptoms would correspond with
a low ACQ score (<0.75). When asked to rate their symp-
toms18/20 (90%) participants reporting moderate to
extremely severe symptoms also had a high ACQ score (OR
60.0, <0.0001), while 12/23 (52%) who reported slight to no
symptoms also had a low ACQ score (OR 9.8, PZ 0.0075). A
high ACQ score also corresponded with reporting of poor
asthma control (OR 8.5 P Z 0.002), any degree of restric-
tion (OR 25.3, PZ 0.0003), frustration (OR 8.5, PZ 0.006)
or emergency GP visit (OR 12.0, P Z 0.001) [Table 3].Refinement of the PACT
Item reduction
Within the overall ANQ survey there were a total of 69 core
variables after sub variables and the demographic data
were excluded. A total of 19 factors were identified,
explaining 72% of the variance in the data. As predicted,
the variables revealed weak correlations, requiring a large
number of factors to explain variance. In measures believed
to assess different characteristics, low correlations are
expected. A factor loading of greater than 0.40 is consid-
ered a reasonable indication of association.18 The overall
structure variables loaded lightly with many items loading
on multiple factors and no item weighing above 0.41 on any
factor and most weighing below 0.20.
Questions unrelated to patient concerns were removed
and re-analysis. When analysed within the separate
domains the association between variables produced higher
factor loading (>0.4), confirming higher correlations within
these theoretical constructs. Cost concerns were identified
by the researchers as a repetitive question, and so a stand-
alone question on cost was grouped with other concerns
relating to non-adherence to medication treatment.
A total of 14 items remained. Factor analysis of the
constructs of the new PACT by principle component analysis
using an oblique rotation produced 4 factors [Table 4].
Items were highly associated, all items loaded on a partic-
ular factor and no item cross loaded.
Pilot testing
Twenty six participants tested the final version of the PACT
to measure its face validity. Testing revealed difficulty
interpreting the question ‘how well do you think you
understand the different types of asthma treatment avail-
able for you?’ as it was worded in the new PACT structure.
This was changed to ‘how well do you understand your
different types of asthma medication?’ “access to GP” was
also changed to “access to medical services” for wider
usage.
Table 2 Correlation of the PACT variables with other validated tools (Spearman’s rank correlation coefficient).
Variable Field sample (n Z 41) Community sample (n Z 44)a
ACQ score (n Z 41) Adherence (n Z 41) ACQ score (n Z 43) Adherence (n Z 32)
rS P value rS P value rS P value rS P value
Symptoms reported1 0.41 0.01 e 0.77 <0.0001 e
Asthma control reported2 0.43 0.006 e 0.54 0.0001 e
Restriction experienced3 0.38 0.02 e 0.71 <0.0001 e
Frustration experienced4 0.43 0.007 e 0.53 0.0004 e
Oral steroid use5 0.21 0.2 e 0.44 0.004 e
Emergency GP visit5 0.11 0.5 e 0.59 <0.0001 e
Emergency hospital visit5 0.14 0.4 e 0.31 0.05 e
Hospital admission5 0.20 0.3 e 0.29 0.06 e
Preventer adherence
reported6
e 0.31 0.02 e 0.57 0.0005
Cost concern7 e 0.01 0.9 e 0.22 0.9
Side-effects experienced8 e 0.07 0.7 e 0.23 0.2
Forgetfulness9 e 0.24 0.2 e 0.36 0.1
Scale order for each variable is as follows: 1 None/Slight/Moderate/Severe or Extremely severe. 2 Perfectly/Very well/Fair/Poorly or Not
at all. 3 None/Slight/Moderate/Severe or Extremely severe. 4 None/Slight/Moderate/Extremely. 5 Use within yr/1e2 yrs ago/3e5 yrs
ago/>5 yrs ago/Never. 6 Always/Almost always/Usually/Rarely or Never. 7 Extremely/Moderately/Slightly/Not at all. 8 Never/Rarely/
Sometimes/Frequently/Always. 9 Everyday/<week >day/once week/>once week/Never.
a Community sample n refers to the subsample from the larger sample. Adherence refers to Brook’s adherence to preventer medi-
cation score. 12/44 participants were not currently taking any preventer medication. ACQ score was missing for 1 participant (0.02%).
Variables oral steroid use, emergency GP and ED visit, hospital admission and frustration which appeared in the initial ANQ survey were
do not appear in the final PACT on asthma concerns.
Table 3 Known-groups validity e associations between reported asthma control items and the ACQ.
Item Total High ACQ score Low ACQ score
n Z 43 n (%) OR (95% CI) P value N (%) OR (95% CI) P value
Symptoms
Moderate-extremely severe 20 18 (85.7) 60.0(9.0e400.8) <0.0001 2 (14.3) e
None e slight 23 3 (14.3) e 12 (85.7) 9.8 (1.8e52.4) 0.008
Control
None-fair 20 15 (71.4) 8.5 (2.2e33.6) 0.002 2 (14.3) e
Perfect e very well 23 6 (28.6) e 12 (85.7) 9.8 (1.8e52.4) 0.008
Restriction
Any restriction 25 19 (90.5) 25.3 (4.5e143.3) 0.0003 3 (21.4) e
No restriction 18 2/(9.5) e 11 (78.6) 11.5 (2.5e53.4) 0.002
Frustration
Any frustration 15 12 (57.1) 8.5 (1.9e38.8) 0.006 2 (14.3) e
No frustration 25 8 (38.1) e 10 (71.4) 4.3 (0.8e23.5) 0.09
Oral steroid use
Ever used 20 13 (61.9) 3.7 (1.0e13.5) 0.046 3 (21.4)
Never used 21 7 (33.3) e 11 (78.6) 6.2 (1.4e27.8) 0.02
Emergency GP visit
Every needed 19 15 (71.4) 12.0 (2.7e53.3) 0.001 2 (14.3) e
Never 21 5 (23.8) e 11 (78.6) 9.4 (1.7e51.0) 0.01
Emergency Dept visit
Ever required 11 7 (33.3) 2.3 (0.6e9.5) 0.3 11 (78.6) e
Never 30 13 (61.9) e 3 (21.4) 1.5 (0.3e7.1) 0.6
Hospital admission
Ever hospitalised 11 6 (28.5) 1.5 (0.4e5.8) 0.6 2 (14.3) e
Never 31 14 (66.7) 12 (85.7) 2.8 (0.5e15.5) 0.2
Analysis used community sample sub-study where ACQ data was also collected.
High ACQ was defined as a score of 1.2 and was compared with an ACQ of <1.2.
Low ACQ was defined as a score 0.75 and was compared with an ACQ of >0.75.
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Table 4 Principle component analysis of PACT items.
Variable Factor 1 Factor 2 Factor 3 Factor 4
Item 2 .083 .766 .174 .055
Item 3 .146 .766 .227 .247
Item 4 .196 .822 .154 .130
Item 5 .053 .438 .252 .027
Item 6 .082 .310 .870 .132
Item 7 .039 .294 .864 .170
Item 8 .876 .155 .071 .148
Item 9 .906 .109 .027 .044
Item 10 .822 .116 .012 .171
Item 11 .110 .072 .462 .290
Item 12 .246 .274 .040 .708
Item 13 .045 .134 .089 .770
Cronbachs a .835 .705 .630 .279
Total variance explained 63.3%. Core questions were analysed.
Nominal sub-scaled questions with multiple responses were not
included. Item 1 ‘what symptoms do you experience’, item 13b
‘why do you chose not to take your medication’ and item 14
‘what do you do when your asthma is out of control’ were thus
not included in this analysis. Bold values indicate adequate
factor loading above 0.4.
Table 5 Importance rating of PACT items by general
practitioners (n Z 30)a.
Item Mean (SD)
1- What symptoms have you experienced
over the past month?
4.73 (0.8)
2- How would you rate your asthma
symptoms over the last month?
4.23 (1.14)
3- How well do you think your asthma has
been controlled over the last month?
4.23 (1.07)
4- How much does your asthma restrict
you from living your everyday life?
4.66 (0.90)
5- Do you worry about side effects from
your asthma medication?
4.17 (1.07)
6- How scared are you that you could
have a bad asthma attack?
4.13 (1.11)
7- How worried are you about dying from
asthma?
3.87 (1.31)
8- How confident are you that you know
what to do if you have an asthma attack?
4.53 (0.94)
9- How well do you think you understand
what you are supposed to do to properly
manage your asthma?
4.40 (0.93)
10- How well do you think you understand
the different types of asthma treatment
available to you?
4.24 (1.09)
11- How difficult is it to see your GP when
needed?
4.33 (1.03)
12- How often do you forget to take your
asthma medication?
4.37 (1.00)
13- Do you ever decide not to take any of
your asthma medication?
4.37 (1.00)
14- What do you do when your asthma is
out of control?
4.30 (1.12)
a Values ranged on a 5 point Likert scale from 1 Z not very
important to 5 Z very important.
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tioners. Each item was ranked from not very important to
very important [Table 5]. All questions rated highly, only
question 7 ranking as low as 77% in importance for inclusion
in the overall. Eleven (37%) GPs reported that overall the
PACT was very easy or easy to use, and no GP responded
that they found it difficult to use.
Reliability and internal consistency
The testeretest repeatability of the PACT variables is
shown in Table 6. Most items showed good to very-good
reliability (0.6 < Kappa/ICC < 1.0). Lower repeatability
(0.4 < Kappa/ICC < 0.6) was observed in the items covering
symptoms experienced within the past month and actions
when asthma is out of control.
The items of the PACT also showed good internal
consistency. The overall Cronbach’s a coefficient for the 14
item PACT was a Z 0.699.
Discussion
This study was undertaken to develop and validate a reli-
able, self-administered questionnaire that could be used to
identify the unmet needs of older people with asthma, and
so help guide communication and asthma management
within the clinical setting. The psychometric testing that
was performed to create this tool was built on an analysis of
the challenges facing older Australians with asthma, the
specific needs and concerns they have regarding their
condition and the management of their symptoms. Our
PACT questionnaire provides a robust validated instrument,
applicable and acceptable to general practitioners, with
which to explore and define the unmet needs of older
people with asthma. Although this hypothesis is yet to be
tested, we believe the use of the PACT in clinical care will
facilitate tailored asthma management and education toimprove current asthma management behaviours and
outcomes in older people.
The initial ANQ survey showed good reliability and val-
idity for collecting information on the concerns of older
people with asthma. The resulting PACT tool also displayed
good psychometric properties for its stand-alone use. The
factor structure of the refined PACT indicated a high level
of correlation around the factors that were produced. The
overall internal consistency in the PACT met the 0.70
satisfactory point suggested by Nunnally.20 Correlations too
low are generally considered to imply items are measuring
different constructs, however particularly strong correla-
tions can indicate item redundancy.18 A higher overall
consistency is not crucial for a tool covering a wide area of
patient concerns. In such instances retaining good content
validity is considered more critical.21
The PACT indicated good reliability. Using Byrt (1996)
Kappa descriptions for repeatability, the overall repeat-
ability of the questionnaire was good.22 The few questions
with low repeatability levels asked about particular symp-
toms and actions taken when asthma is out of control. This
is a relatively small study and tighter repeatability may be
seen in a much larger sample. Regarding symptoms, the low
Table 6 Intra-rater reliability of the PACT.
Kappa/ICC P value 95% CI
Classificationa
Rate symptoms 0.719 0.003 0.308e0.886 Good
Asthma control 0.859 0.000 0.654e0.943 Very good
Restriction from everyday living 0.716 0.003 0.301e0.885 Good
Worry about medication side effects 0.818 0.000 0.540e0.928 Very good
Scared about a bad asthma attack 0.872 0.000 0.683e0.948 Very good
Worried about dying from asthma 0.897 0.000 0.746e0.958 Very good
Confidence in knowing what to do during
asthma attack
0.601 0.023 0.017e0.838 Good
Understanding of what do to properly
manage an attack
0.651 0.011 0.141e0.859 Good
Understanding of the different types of
asthma treatments available
0.765 0.001 0.421e0.905 Good
Access to medical 0.653 0.011 0.146e0.753 Good
Forget 1.000 0.000 0.999e1.0 Excellent
Decision to not take preventer medication 0.894 0.000 0.691e1.0 Very good
Symptoms experienced (included shortness
of breath, cough, sputum, wheeze, chest tightness,
waking at night)
0.113e0.806b e e Slight-excellent
Action when symptoms are out of control
(call ambulance, GP, visit GP, visit specialist,
take medication, follow action plan, rest, breathing
exercises & no action)
0.222e0.774b e e Slight-excellent
a Classification as per Byrt (1996) proposed description.
b Kappa presented as the min and max K in the range of nominal sub-items for symptoms experienced and actions taken.
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variable nature of the disease, but the correlation with the
ACQ suggests this reporting is internally consistent from
time to time. The variation in responses regarding action
taken when asthma is out of control’ rather highlights that
the management of exacerbations by older people is an
education area requiring more serious attention.
Item variables also correlated well with other validated
questionnaires. Items regarding asthma control discrimi-
nated between patients reporting symptoms and asthma
control with high or low ACQ scores. Items also correlated
with the Brook’s adherence score, particularly for
preventer adherence. Although our literature review sug-
gested that adherence scores would also correlate with
concern about medication costs, experience of side effects
and forgetfulness, these associations were not significant in
our study.
Had items been analysed in the first sample only,
psychometric testing may have been limited. However
results between samples confirmed findings. The commu-
nity sample in particular demonstrated higher correlation
with other tools. This sample was more representative of
the general community and not selected from an institute
database or regular out-patient department. This is likely
to explain the differences in criterion-related validity
between samples. Potential bias from recruitment within
the pharmacy setting is however noted, and further analysis
will need to encompass a larger group. The aim of devel-
oping this tool was not to provide a scoring system, rather
a guide to unvoiced or overlooked management needs.
Psychometric testing of the tool against the ACQ and
adherence questionnaire was used to validate self reportedsub components of the tool. Ascertaining the minimal
clinically important difference in patient reporting
following use of the tool in practice remains the next step
in ongoing validation, and testing will be required in
a younger-aged cohort to validate its applicability more
widely.
Notwithstanding, our careful construction and testing of
the instrument does mean that our questionnaire is well-
validated in a group of older people with asthma drawn
from community settings and is likely to be applicable to
them.
Any tool that is psychometrically sound also needs to be
clinically useful e to be utilised in practice.19 The PACT has
yet to be tested in terms of achieving better outcomes, but
a group of general practitioners participating in an educa-
tion initiative perceived it to be very useful for guiding and
assisting practitionerepatient communication. Their opin-
ions suggest that a study to assess the feasibility and
outcomes of using such a tool in the management of asthma
in older people would be worthwhile.
It has been suggested that patient failure to voice
concerns or report symptoms may contribute to sub-
optimal asthma control.23 Effective communication of
concerns is important not only to patient satisfaction but
also to achieving greater adherence to management
recommendations. Our results establish that the PACT is
a valid, reliable method for identifying the unmet needs
and concerns of older people with asthma. We hypothesise
that use of this questionnaire to identify older patient’s
needs will contribute to better asthma outcomes through
promoting the delivery of care tailored to individual
needs.
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